A pharmaceutical company needs to know if its new cholesterol drug. Praxor, is effective at lowering cholesterol levels. It believes that people who take Praxor will average a greater decrease in cholesterol level than people taking a placebo. After the experiment is complete, the researchers find that the 38 participants in the treatment group lowered their cholesterol levels by a mean of 23.2 points with a standard deviation of 4.4 points. The 44 participants in the control group lowered their cholesterol levels by a mean of 21.5 points with a standard deviation of 2.9 points. Assume that the population variances are not equal and test the company's claim at the 0.01 level. Let the treatment group be Population 1 and let the control group be Population 2. Step 3 of 3: Draw a conclusion and interpret the decision. Answer 国 Tables E Keypad Keyboard Shortcuts We reject the null hypothesis and conclude that there is insufficient evidence at a 0.01 level of significance to support the company's claim that people who take the drug will average a greater decrease in cholesterol level than people taking a placebo. We fail to reject the null hypothesis and conclude that there is sufficient evidence at a 0.01 level of significance to support the company's claim that people who take the drug will average a greater decrease in cholesterol level than people taking a placebo. We reject the null hypothesis and conclude that there is sufficient evidence at a 0.01 level of significance to support the company's claim that people who take the drug will average a greater decrease in cholesterol level than people taking a placebo. We fail to reject the null hypothesis and conclude that there is insufficient evidence at a 0.01 level of significance to support the company's claim that people who take the drug will average a greater decrease in cholesterol level than people taking a placebo.
A pharmaceutical company needs to know if its new cholesterol drug. Praxor, is effective at lowering cholesterol levels. It believes that people who take Praxor will average a greater decrease in cholesterol level than people taking a placebo. After the experiment is complete, the researchers find that the 38 participants in the treatment group lowered their cholesterol levels by a mean of 23.2 points with a standard deviation of 4.4 points. The 44 participants in the control group lowered their cholesterol levels by a mean of 21.5 points with a standard deviation of 2.9 points. Assume that the population variances are not equal and test the company's claim at the 0.01 level. Let the treatment group be Population 1 and let the control group be Population 2. Step 3 of 3: Draw a conclusion and interpret the decision. Answer 国 Tables E Keypad Keyboard Shortcuts We reject the null hypothesis and conclude that there is insufficient evidence at a 0.01 level of significance to support the company's claim that people who take the drug will average a greater decrease in cholesterol level than people taking a placebo. We fail to reject the null hypothesis and conclude that there is sufficient evidence at a 0.01 level of significance to support the company's claim that people who take the drug will average a greater decrease in cholesterol level than people taking a placebo. We reject the null hypothesis and conclude that there is sufficient evidence at a 0.01 level of significance to support the company's claim that people who take the drug will average a greater decrease in cholesterol level than people taking a placebo. We fail to reject the null hypothesis and conclude that there is insufficient evidence at a 0.01 level of significance to support the company's claim that people who take the drug will average a greater decrease in cholesterol level than people taking a placebo.
MATLAB: An Introduction with Applications
6th Edition
ISBN:9781119256830
Author:Amos Gilat
Publisher:Amos Gilat
Chapter1: Starting With Matlab
Section: Chapter Questions
Problem 1P
Related questions
Question
Transcribed Image Text:A pharmaceutical company needs to know if its new cholesterol drug, Praxor, is effective at lowering cholesterol levels. It believes that people who take Praxor will
average a greater decrease in cholesterol level than people taking a placebo. After the experiment is complete, the researchers find that the 38 participants in the
treatment group lowered their cholesterol levels by a mean of 23.2 points with a standard deviation of 4.4 points. The 44 participants in the control group lowered their
cholesterol levels by a mean of 21.5 points with a standard deviation of 2.9 points. Assume that the population variances are not equal and test the company's claim at
the 0.01 level. Let the treatment group be Population 1 and let the control group be Population 2.
Step 3 of 3: Draw a conclusion and interpret the decision.
田 Tables
E Keypad
Answer
Keyboard Shortcuts
We reject the null hypothesis and conclude that there is insufficient evidence at a 0.01 level of significance to support the company's claim that people who take the
drug will average a greater decrease in cholesterol level than people taking a placebo.
We fail to reject the null hypothesis and conclude that there is sufficient evidence at a 0.01 level of significance to support the company's claim that people who take the
drug will average a greater decrease in cholesterol level than people taking a placebo.
We reject the null hypothesis and conclude that there is sufficient evidence at a 0.01 level of significance to support the company's claim that people who take the drug
will average a greater decrease in cholesterol level than people taking a placebo.
We fail to reject the null hypothesis and conclude that there is insufficient evidence at a 0.01 level of significance to support the company's claim that people who take
the drug will average a greater decrease in cholesterol level than people taking a placebo.
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 2 steps with 3 images
Recommended textbooks for you
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
Elementary Statistics: Picturing the World (7th E…
Statistics
ISBN:
9780134683416
Author:
Ron Larson, Betsy Farber
Publisher:
PEARSON
The Basic Practice of Statistics
Statistics
ISBN:
9781319042578
Author:
David S. Moore, William I. Notz, Michael A. Fligner
Publisher:
W. H. Freeman
Introduction to the Practice of Statistics
Statistics
ISBN:
9781319013387
Author:
David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:
W. H. Freeman